populations. 1 For example, obesity has been consistently associated with an increased risk of mortality and cardiovascular disease in reproductive-aged adults, while this association is less clear among the elderly. 2, 3 Similar findings, discordant for reproductive-aged vs elderly populations, have been noted in the migraine literature, with multiple, large general population studies supporting increased odds of migraine and severe headaches with obesity among reproductive-aged participants, [4] [5] [6] [7] but no such association was observed among older participants. 5, 8, 9 While these findings could truly be due to a change in the association between risk factors and disease state in aging populations, other explanations are also possible. One possibility is that the impact or implication of a given BMI differs between younger and older individuals. 1, 10 Specifically, investigators have shown that with advancing age, the ratio of adipose tissue to FFM increases -even in individuals who maintain the same BMI. Thus, using the same definition of obesity (based on a BMI cut-point) in older and younger adults may not be appropriate. Another possibility may be that the BMI, in general, is not adequate in terms of indicating adiposity in older populations. 1, 10 In addition to demographic factors, how obesity is estimated in studies evaluating obesity can also impact the reported findings. Although most anthropometric measures of obesity conform reasonably well in predicting future disease status, differences may exist in evaluating short-term effects and effects on specific disease entities. Given that obesity is defined as excessive adipose tissue in relation to FFM, obesity is most accurately estimated by direct demonstration of an increase in adipose tissue to FFM, such as with computed tomography or magnetic resonance imaging. 10 However, direct measurements are not practical and are prohibitively expensive for large population-based epidemiological studies. Thus, indirect estimates of general or total body obesity (TBO), based on the BMI, and of regional or abdominal obesity, based on waist circumference measurements, are often used. Consequently, in the published studies evaluating migraine and obesity to date, obesity is defined as excess in relative body weight (which includes skin, organs, and muscle mass, in addition to adipose tissue mass) rather than just excessive adipose tissue mass. 1, 10 Further, given that anthropometrics are estimates of obesity -even when height and weight are measured -the use of selfreported height and weight to calculate BMI may substantially underestimate potential obesity associations. 11 This underestimation may result from participants' tendency to overestimate their height and underestimate their weight when self-reported. 12 Hence, even in prospective cohort studies, when BMI is based on self-report, nondifferential misclassification of participants' obesity status (ie, TBO is ascertained before incident migraine) may result in spuriously low relative risk estimates. 10, 11 Thus, it is important to recognize if BMI is estimated by selfreport of height and weight (BMI-sr), or by measured height and weight (BMI-m) in studies evaluating the migraine-obesity association. 11 It is also important to note that as long as these potential limitations are kept in mind, the BMI can and has been a valuable and cost-efficient tool to evaluate disease associations, including migraine and obesity.
Is There an Association Between Episodic and Chronic Migraine and Obesity in Women, Men, and Adolescents?-In both cases earlier, the women were overweight or obese since childhood, with the onset of episodic migraine as adolescents. In one case, the pattern progressed to a chronic pattern. Obesity has been shown to be associated with both episodic and chronic headache among reproductive age subjects in multiple studies. [5] [6] [7] 13, 14 (See Tables 1 and 2 .) However, all studies have consistently demonstrated no association between obesity and migraine in postreproductive-aged individuals. 5, 8, 9 (See Table 3 .) The first study to identify an association between episodic headache and obesity was a longitudinal study by Scher and colleagues in 2003. 13 A total of 1932 participants between 18 and 65 years of age were evaluated, of whom 798 participants were episodic headache sufferers with 2-104 headache days per year (ie, <9 headache days/month) and 1134 were chronic daily headache (CDH) sufferers (ie, Ն15 headache days/month). Individuals with episodic headache who were obese (BMI-sr) had over a 5-fold increased odds of developing CDH at the second interview (odds ratio [OR] 5.53; 95% 
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Measured TBO Non-ICHD Individually by each group, those with recurrent headache in general, recurrent migraine, or recurrent tension-type headache were more overweight or obese than those without headache. Those with migraine were more overweight or obese (BMI-m) than those without migraine (OR 1.6; CI: 1.4-2.2). Those with tension-type headache were more obese (BMI-m) than those without tension-type headache (OR 1.4; CI: 1.1.-1.6). Abd-OB Non-ICHD In older men, the odds of migraine were not associated with total body obesity (BMI-m) or abdominal obesity (WC).
Ab-OB

Abd-OB
In older women, the odds of migraine were not associated with total body obesity (BMI-m).
In older women, the odds of migraine were decreased in those with abdominal obesity (WC). confidence interval [CI]: 1.4-21.8) as compared with those episodic headache sufferers without obesity. 13 Scher's study was subsequently followed by 2 small clinic-based studies, 15, 16 as well as multiple large, general population cross-sectional studies. 10 Notably, studies that failed to document positive associations of episodic headache or migraine with obesity did not fully account for possible effect modification by participants' age (eg, different associations for reproductive age and older participants). Additionally, those studies relied on self-reported body mass indices to estimate obesity. 10 In contrast, studies that accounted for reproductive age or those that used objective measures of obesity confirmed significant associations of episodic headache and migraine with obesity in reproductive-aged adolescents and adults. [4] [5] [6] [7] (See Table 1 for a detailed summary of relevant studies.)
In the first general population study evaluating the migraine-obesity association utilizing measured body mass indices (BMI-m), Ford et al evaluated 7601 participants in the National Health and Nutrition Examination Survey (NHANES), ranging from 20 to 85 years of age. 4 Migraine and severe headaches were self-reported. Those with obesity had a 37% increased odds for having migraine compared with those of normal weight (OR 1.37; 95% CI: 1.09, 1.72).
Following the Ford study, and also utilizing the NHANES database, Peterlin et al demonstrated that the migraine-adiposity association varies by age, sex, and adipose tissue distribution pattern (eg, TBO vs Abd-O). In their sample of over 15,500 participants, the authors reported that the prevalence of migraine was increased in both younger men and women (20-55 years old) with either TBO (women: OR 1.39; 95% CI: 1.24-1.55; men: OR 1.38; 95% CI: 1.20-1.59) or abdominal obesity (women: OR 1.39; 95% CI: 1.25-1.56; men OR 1.30; 95% CI: 1.13-1.48) -even after adjusting for demographic and cardiovascular confounders. Further, although the association of migraine with abdominal obesity did not remain significant in reproductive-aged men after adjusting for demographics, cardiovascular confounders AND TBO (BMI-m) (OR 1.03; 95% CI: 0.84-1.27), it did remain significant in reproductive-aged women (OR 1.26; 95%CI: 1.10-1.45). Peterlin et al's findings also supported previous studies that demonstrated that migraine was not associated with TBO in older men and women (>55 years of age), and additionally reported that while there was no association between migraine and abdominal obesity in older men, in postreproductive-aged women, migraine prevalence was actually inversely associated with abdominal obesity. These data suggest that prior analyses that failed to account for possible effect modification by age group may have obscured important differences in migraineobesity relations for adolescent and older individuals.
In a third general population study, Vo et al evaluated over 3700 adult premenopausal women in the OMEGA study to evaluate the odds of migraine in those with obesity (BMI-sr). 6 A 48% increased odds of migraine was found in those women with obesity (OR 1.48; 95% CI: 1.12-1.96).
Finally, Robberstad et al evaluated over 5500 adolescents (13-18 years of age) boys and girls in the HUNT Study. 7 Adolescents with recurrent headache in general demonstrated a 40% increased odds of being overweight or obese (BMI-m) (OR 1.4; 95% CI: 1.2-1.6). Similarly those adolescents with migraine demonstrated a 60% increased odds of being overweight or obese (BMI-m) (OR 1.6; 95% CI: 1.4-2.2). 7 In addition to episodic headache, there is also an association between chronic headaches and obesity. The 2003 longitudinal study by Scher and colleagues demonstrated that the prevalence of CDH was increased in those who were obese (BMI-sr) (OR 1.34; CI: 1.0-1.8) or overweight (OR = 1.26; CI: 1.0-1.7). 13 This finding was later confirmed by Bigal and Lipton in a study of over 30,000 participants, of which 1243 individuals fulfilled criteria for CDH.
14 Of the CDH participants, approximately 401 fulfilled criteria for transformed migraine and 863 fulfilled criteria for chronic tension-type headache (CTTH). As in the Scher study, investigators noted a positive trend of increasing CDH prevalence with increasing categories of self-reported BMI. The prevalence for successive BMI-sr categories were as follows: 18.5-24.9 kg/m 2 (3.9%), 30-34.9 kg/m 2 (5.0%), and Ն35 kg/m 2 (6.8%). In addition, Bigal and Lipton showed that the association between CDH and obesity was stronger with transformed migraine than in CTTH, with the prevalence of transformed migraine being associated with those with a BMIsr Ն 30, while the prevalence of CTTH was only associated with those with a BMI-sr Ն 35.
14 No large, general population studies have evaluated the association between CDH and abdominal obesity. However, a small clinic-based study of 27 women of reproductive age is of note as the first study to evaluate abdominal obesity in migraineurs and CDH sufferers with chronic migraine or medication overuse headache. 17 Although the primary aim of the study was to compare serum levels of adiponectin among healthy controls, episodic migraineurs, and CDH sufferers, body mass indices were measured, including waist and hip circumference. Despite participants having been matched based on BMI, the women with CDH had a greater frequency of abdominal obesity based on the waist to hip ratio (33%) as compared with episodic migraineurs (8.3%) and controls (0%), P = .049.
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What Might Be the Mechanism?-Adipose tissue is a functioning, active endocrine organ that influences energy homeostasis, reproduction, and inflammatory process, among other metabolic processes. Biological mechanisms underlying consistently observed associations of obesity and episodic and chronic migraine (particularly among reproductive aged population) are likely to be multifactorial, and to involve both peripheral and central pathophysiological processes. A detailed discussion on these biologically plausible mechanisms has recently been published. 10 Peripherally, expansion of adipose tissue during weight gain leads to the recruitment of macrophages and T cells, as well as changes in the synthesis of cytokines and adipocytokines by adipocytes that favor chronic systemic inflammation and insulin resistance. Weight gain, which is known to lead to the induction of several pro-inflammatory cytokines (eg, tumor necrosis factor-a, interleukin [IL]-1 and IL-6), 10, 18 may in turn contribute to local and systemic inflammation. Elevated plasma concentrations of pro-inflammatory cytokines and alterations in adipocytokines have been implicated in the pathogenesis of migraine.
Centrally, the regulation of feeding is controlled by the system involving the arcuate nucleus of the hypothalamus and its connections. Hypothalamic involvement in migraine was initially suggested based on the observations of premonitory symptoms in migraineurs, such as changes in thirst, food cravings, mood, and sleep disturbances. 10 More recently, functional imaging data have demonstrated hypothalamic activation during acute migraine attacks. 19 It has also been demonstrated that several hypothalamic peptides, proteins, and neurotransmitters involved in feeding have been implicated in migraine pathophysiology. Notably, these include serotonin, adiponectin, leptin, and orexin. 
Does Weight Gain or Loss Have an Effect on
Migraine Frequency?-In the first case, the patient's headache pattern progressed from an episodic to a chronic pattern in association with a progression of obesity status from adolescence to adulthood. To date, no longitudinal studies have evaluated the effect of weight gain on migraine frequency. However, in a cross-sectional study, Vo et al demonstrated that the risk of migraine in reproductive-aged women substantially increased with increasing severity of obesity. 6 Specifically, while the overall odds of migraine in women with obesity of any level was 48% greater than women without obesity (OR 1.48; 95%CI: 1.12-1.96), those women with severe or class II obesity (BMI 35-39.9) had over a 200% increased risk (OR 2.07; 95%CI: 1.27-3.39), and those with morbid or class III obesity (BMI Ն 40) had a 275% increased risk of migraine (OR 2.75; 95%CI: 1.60-4.70). 6 Further, Vo et al demonstrated that women with a history of pediatric migraine had a 67% increased odds of gaining Ն22 pounds above their weight at the age of 18 (OR 1.67; 95% CI: 1.13-2.47). 6 It is possible that a similar weight gain occurred in the first case. This weight gain may, thus, have resulted in a progression of her obesity classification from being overweight to obese and ultimately with her increasing headache frequency.
Finally, 2 small clinical studies that evaluated headache frequency in low-frequency episodic migraineurs following weight loss from bariatric surgery are worthy of note. In these studies, the monthly headache frequency declined from approximately 4 headache days per month at baseline to just 1 to 2 headache days per month 6 months following surgery. However, while these studies are suggestive that weight loss is associated with a decline in headache frequency in episodic migraineurs, larger, controlled studies will be needed to substantiate these findings and determine the true-effect size before bariatric surgery can be considered as part of treatment for migraine therapy.
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Should the Potential Effects of Medications on Weight Be Considered in Treating Obese Migraineurs?-Clinicians treating obese migraine patients should consider providing their patients with access to lifestyle education -particularly in terms of promoting healthy diet and exercise routines. Lack of physical activity has been demonstrated to be associated with a 21% increased risk of headache attacks in adult migraineurs (hazard ratio [HR] 1.209; P < .01), 21 and a 50% increased risk of migraine in adolescents (OR 1.5; 95%CI: 1.0-2.2). 7 In addition, aerobic activity may reduce headache frequency in episodic migraineurs. 22, 23 Particular care should also be taken by physicians in regard to their choices of medications prescribed to migraine patients, given that many migraine medications can affect weight either positively or negatively. Several medications that may be used for migraine prevention may also be associated with weight loss, and include topiramate, zonisamide, and protriptyline. 24, 25 Other potential migraine preventive agents where weight loss is mild or neutral include duloxetine and venlafaxine. Verapamil, propranolol, and gabapentin, may be associated with mild to moderate weight gain or be weight neutral. In contrast, valproic acid, amitriptyline, and flunarizine may be associated with substantial weight gain. 24, 25 In summary, migraine is associated with obesity in those of reproductive age -the age when migraine is most prevalent. 26 Given that obesity is a modifiable risk factor, we should actively provide all migraine patients with education on the association of episodic and chronic migraine with obesity in general, as well as the increasing risk of migraine associated with increasing obesity, and the potential effect of weight gain and weight loss on headache frequency. Additionally, although longitudinal studies are needed to better characterize the influences migraine medications may have on energy balance and a patient's propensity to gain or lose weight, migraine patients should be made aware of the potential influence medications may have on their weight, and they should be encouraged to exercise, consume a healthy diet, and avoid excessive weight gain.
